Coronary Stents Market
                                                  Coronary Stents Market
Stents are medical devices intended to use for the treatment of blocked 
vascular paths and the procedure used to reduce the blockages is known as 
percutaneous transluminal coronary angioplasty (PTCA). The stents used for 
arterial blockage are known as coronary stents or heart stents. Coronary stents 
can be either of the three types, which are bare metal stents, drug eluting 
stents, and bioabsorbable stents. Although bare metal stents dramatically 
improves angiographic and clinical outcome of patients, the rate of restenosis is 
20–30%. This is a major factor limiting the usage of bare metal stents and 
development of next generation of drug eluting stents.
The global coronary stents market size is estimated to be valued at US$ 7,814.4 
million in 2018, and is expected to witness a CAGR of 6.8% over the forecast 
period (2018 – 2026).
Get the sample 
link:-https://www.coherentmarketinsights.com/insight/request-sample/2031 
Increasing adoption of stents implantation in cardiovascular blockage is a major 
factor for the coronary stents market growth
Stents implantation being non-invasive surgery is increasingly gaining popularity 
as compared to more invasive bypass surgeries, owing to lower rate of 
discomfort and shorter recovery time. Moreover, cardiovascular diseases are 
considered as the leading cause of morbidity and mortality across the world, in 
turn fueling demand for coronary stents.  According to American Heart 
Association, 2015, more than 17.3 million people die every year due to 
cardiovascular disease.
Moreover, increasing research initiatives by local manufacturers to enhance 
their regional coronary stents market share is boosting the coronary stents 
market growth. For instance, Qvanteq, a Switzerland-based company, is 
engaged in developing Qstents, a coronary stent system, consisting of various 
length and diameter combinations, in collaboration with Cardialysis BV, a 
specialized Clinical Research Organization (CRO). Such research by local 
manufacturers are expected to provide products at relatively lower cost, thus 
increasing affordability and in turn the product usage. This is expected to aid in 
the market growth.
Moreover, technological advancement such as nano-coated coronary stents are 
propelling its adoption, thus aiding in the market growth. For instance, in 2017, 
CeloNova BioSciences Inc. is evaluating its proprietary Cobra PzF Nanocoated 
Coronary Stents (NCS) in patients with high bleeding risk. Nanocoated coronary 
stents are alternate therapy for patients incompatible to drug eluting stents and 
long term antiplatelet therapy.
Factors such as risky stent implantation is expected to negatively affect growth 
of the market. For instance, stents implantation is prone to stents displacement 
and re-narrowing of the arteries. Re-blockages are addressed by administering 
blood-thinning drugs, which is leading to high adoption of drug eluting coronary 
stents.
Coronary Stents Market Regional Outlook - Asia Pacific to be the fastest growing 
market over the forecast period
In terms of region, the coronary stents market is segmented into North America, 
Latin America, Europe, Asia Pacific, Middle East, and Africa by Coherent Market 
Insights. Europe holds dominant position in the coronary stents market, owing 
to presence of large obese population with high risk of coronary blockage in the 
region.
According to European Heart Network’s European Cardiovascular Disease 
Statistics 2017, in 2015, new cases registered with cardiovascular disease in 
Europe was around 11.3 million with nearly 6.1 million new cases of 
cardiovascular disease in the European Union. The number is further expected 
to increase with increase in the rate of obese population.
Get PDF :-https://www.coherentmarketinsights.com/insight/request-pdf/2031
However, Asia Pacific coronary stents market is expected to witness significant 
growth due to lower surgical cost in emerging countries such as India and China, 
which is attracting medical tourist. For instance, countries like Thailand and 
Malaysia is the most preferred destination for medical tourist, owing to its 
competitively affordable medical services. According to Malaysia Healthcare 
Travel Council, the country is expected to host medical facilities for more than 
one million medical tourist, accounting for revenues of US$ 310.4 million for 
2017.
Moreover, increasing expansion of regional key players in the other regions is 
also expected to influence the regional market growth. For instance, in April 
2018, Terumo Corporation, Tokyo-based medical device company, received CE 
mark for Ultimaster TANSEI drug-eluting stent, which was launched in the 
European market in May 2018. Furthermore, the company also aims to expand 
in Middle East, Latin America, and Asia in the near future.
Key players in the global coronary stents market
Major players operating in the coronary stents market include Boston Scientific 
Corporation, Abbott, Medtronic plc, B. Braun Melsungen AG, Stentsy SA, 
Terumo Interventional Systems, Kyoto Medical Planning Co., Ltd., QualiMed, 
Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth 
Medical, Inc. and Arterial Remodeling Technologies SA
Get more 
info:-https://www.coherentmarketinsights.com/market-insight/coronary-stent
s-market-2031
Mr. Raj Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Website: https://www.coherentmarketinsights.com
Visit Our Blog: http://bit.ly/snowy
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm 
offering action-ready syndicated research reports, custom market analysis, 
consulting services, and competitive analysis through various recommendations 
related to emerging market trends, technologies, and potential absolute dollar 
opportunity.